EVERSANA, a provider of next-generation commercial services to the global life sciences industry, has launched NAVLIN, described as a “comprehensive ecosystem of price and access solutions to help established and emerging pharmaceutical companies navigate global market access complexities.” The company reports that NAVLIN combines best-in-class data, software and insights into an integrated platform, backed by a team of innovative industry experts.
For ecosystem users, NAVLIN offers price and access data to set global pricing strategies and then apply those strategies to proprietary reference pricing. Additionally, the platform is said to provide in-depth market research insights into market access all the way through patient access.
Within the NAVLIN ecosystem, clients have unified access to
For more information, visit NAVLIN.COM.
Elevate Your Commercial Operations with Close-up CRM
September 6th 2024Discover a powerful, cost-effective, and robust CRM platform that maximizes your budget. Seamlessly integrate data from any source, streamline marketing efforts, and optimize HCP promotion, key account management, and digital marketing campaigns. Reduce CRM costs and reallocate funds to enhance data analytics, market research, and human capital, boosting overall commercial operations impact.
AI-Enabled Pharma CRM Driving Intelligent Customer Engagement
September 6th 2024Discover our unparalleled CRM solution that integrates AI/ML for enhanced stability, security, and performance. Leverage our team of 1000+ experts and 25K+ data provider partners. Our cloud-based SaaS model allows rapid global deployment and scalability, while our clean UX focuses on intuitive AI experience and rapid user adoption. Ensure swift 80% physician onboarding with our intuitive AI platform, speeding strategic integration.